PMC6454642_01
Changes in liver function, triglycerides levels, and glycometabolism over the
time of clonazepam administration and discontinuation.
10.1177_2050313X19842976-fig1.jpg
PMC6454642_01_10.1177_2050313X19842976-fig1.jpg
fig1-2050313X19842976
The levels of markers for glycometabolism, such as fasting glucose, HbA1c, and GA, decreased to 107 mg/dL, 6.1%, and 11.8%, respectively (Figure 1), and did not increase thereafter.